How lookalike medicines can cause harm to patients Involving clinicians in the design of drug packaging would help reduce the number of lookalike medicines and lower the risk of dispensing errors and patient harm.…
MHRA reviews liquid ranitidine packaging after audit of dispensing incidents The UK medicines safety regulator is reviewing the packaging of liquid ranitidine after an audit of dispensing incidents involving children.…
Risk of hyperglycaemia for diabetes patients using faulty insulin pensPeople with diabetes using insulin pens from a number of faulty batches manufactured by Owen Mumford are at risk of hyperglycaemia.…
GlaxoSmithKline revises colour and labelling of Relvar Ellipta inhaler GlaxoSmithKline is changing the colour of its Relvar Ellipta inhaler from blue to yellow after respiratory health professionals warned that patients could be confused.…
Is it art to exploit the drug industry’s designs? The Paul Stolper Gallery is hosting the latest pharmacy-inspired Damien Hirst exhibition. Andrew Haynes questions whether this is art or exploitation.…
The package user test: a method for improving medicines packagingThis paper describes a new performance-based package user test that has the potential to improve drug package design and therefore reduce drug selection errors.…